SOPH Form 144: 380 RSUs notified for resale

SOPH (Form 144) reports a notice to sell 380 restricted stock units of Common Stock dated 04/18/2026.

Rhea-AI Filing Summary

SOPH (Form 144) reports a notice to sell 380 restricted stock units of Common Stock dated 04/18/2026. The filing also lists multiple Rule 10b5-1 open-market sales by Manuela Valente totaling several transactions in Feb–Apr 2026, with individual sell amounts and gross proceeds reported.

Insights

Securities Compliance Analyst

Routine Rule 144 notice with 10b5-1 sales listed; compliance disclosure rather than material corporate action.

The filing lists a notification to sell 380 restricted stock units dated 04/18/2026 and several 10b5-1 sales by Manuela Valente on 02/19/2026, 03/19/2026, 04/06/2026, 04/07/2026, and 04/08/2026. This is a resale disclosure under Rule 144 and routine for affiliated holders.

Cash‑flow treatment and whether the 380 RSUs are being sold immediately are not specified in the excerpt; subsequent SEC filings or broker reports would show settlement details if relevant.

Key Figures

RSUs notified: 380 shares 10b5-1 sale (04/08/2026): 3,824 shares 10b5-1 sale (04/07/2026): 2,376 shares +3 more

6 metrics

RSUs notified 380 shares Restricted Stock Units dated 04/18/2026

10b5-1 sale (04/08/2026) 3,824 shares Gross proceeds $18,542.58 on 04/08/2026

10b5-1 sale (04/07/2026) 2,376 shares Gross proceeds $11,565.89 on 04/07/2026

10b5-1 sale (04/06/2026) 2,597 shares Gross proceeds $12,583.24 on 04/06/2026

10b5-1 sale (03/19/2026) 380 shares Gross proceeds $1,818.34 on 03/19/2026

10b5-1 sale (02/19/2026) 380 shares Gross proceeds $1,833.88 on 02/19/2026

Key Terms

Form 144, 10b5-1 Sales, Restricted Stock Units

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 Sales regulatory

"10b5-1 Sales for MANUELA VALENTE ... | Common | 04/08/2026"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Restricted Stock Units financial

"Securities To Be Sold ... Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does SOPH's Form 144 disclose?

It discloses a notice to sell 380 restricted stock units dated 04/18/2026 and multiple 10b5-1 sales by Manuela Valente in Feb–Apr 2026, with per-transaction share counts and gross proceeds listed.

Who conducted the open-market sales listed on the SOPH Form 144?

The report lists multiple 10b5-1 sales by Manuela Valente, with transactions on 02/19/2026, 03/19/2026, 04/06/2026, 04/07/2026, and 04/08/2026, each showing shares sold and gross proceeds.

How many shares were sold on April 8, 2026 in the filing?

The filing shows 3,824 shares sold on 04/08/2026 with reported gross proceeds of $18,542.58 for that transaction, as listed in the excerpt.

Does this Form 144 indicate issuer proceeds or company issuance?

The excerpt lists resale transactions and a notice to sell RSUs; it does not state that the issuer will receive proceeds. The filing is a resale disclosure and does not specify proceeds to the company.

Are the transactions marked as Rule 10b5-1 sales?

Yes. Each open-market sale in the excerpt is labeled as a 10b5-1 Sale, indicating the sales were executed under a pre-arranged trading plan for the reporting holder.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/20/2026 - 04:32 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002009280
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SOPHIA GENETICS SA
SEC File Number	001-40627
Address of Issuer	La Piece 12 ch-1180 Rolle SWITZERLAND 00000
Phone	41216941060
Name of Person for Whose Account the Securities are To Be Sold	MANUELA VALENTE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	380	2006.40	68486338	04/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/18/2026	Restricted Stock Units	Issuer			380	04/18/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	04/08/2026	3824	18542.58
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	04/07/2026	2376	11565.89
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	04/06/2026	2597	12583.24
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	03/19/2026	380	1818.34
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	02/19/2026	380	1833.88

144: Remarks and Signature

Remarks
Date of Notice	04/20/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/03/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Manuela Valente
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)